Pharmaceutical Drugs

Contents:

Research conducted by: RAND Health

All Items (123)

JOURNAL ARTICLE

Probiotics Can Reduce Risk of Diarrhea Caused by Antibiotics — May 8, 2012

Probiotics are believed to improve health by maintaining a normal balance of microorganisms in the human intestines. Evidence shows that they can reduce the risk of developing diarrhea, which is a common side effect of taking antibiotics.

NEWS RELEASE

Probiotics Can Reduce Risk of Diarrhea Caused by Antibiotics — May 8, 2012

Probiotics are believed to improve health by maintaining a normal balance of microorganisms in the human intestines. Evidence shows that they can reduce the risk of developing diarrhea, which is a common side effect of taking antibiotics.

JOURNAL ARTICLE

Medication Adherence to Multi-Drug Regimens — May 1, 2012

The objective of this article was to provide background information about medication adherence and its measurement, the development of the conceptual model for use in adherence research, and supportive intervention strategies such as pharmaceutical care by pharmacists to improve chronic medication use in older adults.

REPORT

Planning for an Aging Nation: New Estimates to Inform Policy Analysis for Senior Health — Apr 12, 2012

Provides insights into the costs and challenges of providing health care to the elderly population.

JOURNAL ARTICLE

Survey Results Show That Adults Are Willing to Pay Higher Insurance Premiums for Generous Coverage of Specialty Drugs — Apr 1, 2012

This study estimated how healthy people value insurance coverage of specialty drugs, defined as high-cost drugs that treat cancer and other serious health conditions like multiple sclerosis, by quantifying willingness to pay via a survey.

REPORT

Focus on Health Information Technology — Mar 30, 2012

For nearly a decade, RAND researchers have studied how health information technology (HIT) stands to change health care.

JOURNAL ARTICLE

Financial Burden of Prescription Drugs Is Dropping, but Costs Remain a Challenge for Many Families — Feb 8, 2012

The financial burden Americans face paying out-of-pocket costs for prescription drugs has declined, although prescription costs remain a significant challenge for people with lower incomes and those with public insurance.

NEWS RELEASE

Financial Burden of Prescription Drugs Is Dropping, but Costs Remain a Challenge for Many Families — Feb 8, 2012

The financial burden Americans face paying out-of-pocket costs for prescription drugs has declined, although prescription costs remain a significant challenge for people with lower incomes and those with public insurance.

JOURNAL ARTICLE

Sources of Regional Variation in Medicare Part D Drug Spending — Feb 1, 2012

Regional variation in Medicare Part D spending for prescription drugs results largely from differences in the cost of drugs selected rather than prescription volume.

JOURNAL ARTICLE

Treatment of Attention-Deficit Hyperactivity Disorder: Patterns of Evolving Care During the First Treatment Episode — Feb 1, 2012

This study sought to better understand factors associated with different patterns of treatment among children starting treatment for attention-deficit hyperactivity disorder (ADHD).

JOURNAL ARTICLE

Early Adopters of Electronic Prescribing Struggle to Make Meaningful Use of Formulary Checks and Medication History Documentation — Jan 1, 2012

In offices where e-prescribing was implemented, prescribers used information about formularies and drug benefits, but missing information reduced confidence in these resources and led to paper-based workarounds.

JOURNAL ARTICLE

High-priority Drug -- Drug Interactions for Use in Electronic Health Records — Jan 1, 2012

A panel of experts highlighted the complexity of issues surrounding development and implementation of a set of high-severity, clinically significant drug–drug interactions (DDIs) for use in electronic health records (EHRs).

JOURNAL ARTICLE

Physician Prescribing Behavior and Its Impact on Patient-Level Outcomes — Dec 1, 2011

Physicians prescribe more broadly than commonly perceived. Though narrow prescribers are more likely to prescribe highly advertised drugs, few physicians prescribe these drugs exclusively. Narrow prescribing has modest effects on medication adherence and out-of-pocket costs in some classes.

JOURNAL ARTICLE

Basing Drug Scheduling Decisions on Scientific Ranking of Harmfulness: False Promise from False Premises — Nov 1, 2011

Multiple dimensions of harm need to be displayed to inform human judgments of what drugs should be scheduled; recent efforts ignores drug interactions and mix aggregate and individual harms inappropriately.

JOURNAL ARTICLE

Meaningful Use of Electronic Prescribing in 5 Exemplar Primary Care Practices — Oct 1, 2011

Widespread implementation and effective use of e-prescribing in ambulatory care will require practice transformation efforts that focus on work process redesign while being attentive to effects on patient and pharmacy involvement in prescribing.

JOURNAL ARTICLE

Today's 'Meaningful Use' Standard for Medication Orders by Hospitals May Save Few Lives; Later Stages May Do More — Oct 1, 2011

Current federal standards for hospital "meaningful use" of health information technology--which requires electronic medication orders for 30 percent of eligible patients--are probably too low to reduce deaths from heart failure and heart attack among hospitalized Medicare beneficiaries.

JOURNAL ARTICLE

Atypical Antipsychotics May Aid Symptoms for Some Off-Label Conditions, but Not Others — Sep 27, 2011

Evidence supports the effectiveness of some atypical antipsychotics in reducing symptoms of generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder and behavioral symptoms in elderly patients with dementia. There is insufficient evidence that the medications are effective for treating eating disorders, substance abuse and insomnia.

NEWS RELEASE

Atypical Antipsychotics May Aid Symptoms for Some Off-Label Conditions, but Not Others — Sep 27, 2011

Evidence supports the effectiveness of some atypical antipsychotics in reducing symptoms of generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder and behavioral symptoms in elderly patients with dementia. There is insufficient evidence that the medications are effective for treating eating disorders, substance abuse and insomnia.

REPORT

Improving Access to Medicine in the Developing World — Sep 19, 2011

Non-communicable diseases (NCDs) such as cancer, diabetes, and cardiovascular disease are common and rising in the developing world, but access to treatment remains limited. An analysis of the obstacles to treatment finds realistic areas for improvement and ideas the pharmaceutical industry could focus on as it develops its NCD policy research program.

JOURNAL ARTICLE

Multisite Cost Analysis of a School-Based Voluntary Alcohol and Drug Prevention Program — Sep 1, 2011

The large cross-school variation in the cost of implementing Project CHOICE (a voluntary after-school prevention program for adolescents) highlights the importance of collecting cost information from multiple sites.

My RAND ?

Saved Items

Recommended

View My Profile

Explore

Broader Topics

Narrower Topics

Similar Topics

Explore All Topics »

Researcher Spotlight

Geoffrey F. Joyce

Codirector, UCLA/RAND Health Services Research Training Program

Geoffrey F. Joyce

Geoffrey F. Joyce is a senior economist at the RAND Corporation, associate professor at the University of Southern California (USC) School of Pharmacy, and senior research faculty member at USC's Leonard D. Schaeffer Center for Health Policy and Economics. His research has been published in…

Walid F. Gellad

Adjunct Researcher

Walid Gellad M.D., is an adjunct researcher at RAND and an assistant professor of medicine at the University of Pittsburgh. He is a faculty member of the Pittsburgh Veterans Administration (VA) Center for Health Equity Research and Promotion (CHERP).

Explore Our People »